Jefferies Reiterates Buy on Catalyst Health Solutions

Jefferies is out with its report today on Catalyst Health Solutions (NASDAQ: CHSI), reiterating Buy.

In its report, Jefferies writes, "We remain bullish on CHSI given our view that the company's transparent PBM model positions it well for robust LT organic growth and market share expansion. Additionally, opportunities to expand generics, mail, and specialty penetration rates, as well as incremental synergies from recent and future acquisitions, position CHSI well to drive robust margin expansion and >25% annual EPS growth over the next several years. Reiterate Buy."

Jefferies maintains a $77 PT on CHSI.

Shares of CHSI closed Friday at $51.64.